Cargando…
CRISPR/dCas9-KRAB-Mediated Suppression of S100b Restores p53-Mediated Apoptosis in Melanoma Cells
Overexpression of S100B is routinely used for disease-staging and for determining prognostic outcomes in patients with malignant melanoma. Intracellular interactions between S100B and wild-type (WT)-p53 have been demonstrated to limit the availability of free WT-p53 in tumor cells, inhibiting the ap...
Autores principales: | Roy Choudhury, Samrat, Heflin, Billie, Taylor, Erin, Koss, Brian, Avaritt, Nathan L., Tackett, Alan J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10000373/ https://www.ncbi.nlm.nih.gov/pubmed/36899866 http://dx.doi.org/10.3390/cells12050730 |
Ejemplares similares
-
Repression of HIV-1 reactivation mediated by CRISPR/dCas9-KRAB in lymphoid and myeloid cell models
por: da Costa, Lendel Correia, et al.
Publicado: (2022) -
Downregulation of CacyBP by CRISPR/dCas9-KRAB Prevents Bladder Cancer Progression
por: Zheng, Hanxiong, et al.
Publicado: (2021) -
CRISPR-dCas9 mediated TET1 targeting for selective DNA demethylation at BRCA1 promoter
por: Choudhury, Samrat Roy, et al.
Publicado: (2016) -
Transcriptional Inhibition of lncRNA gadd7 by CRISPR/dCas9-KRAB Protects Spermatocyte Viability
por: Zhao, Jun, et al.
Publicado: (2021) -
Ezh2-dCas9 and KRAB-dCas9 enable engineering of epigenetic memory in a context-dependent manner
por: O’Geen, Henriette, et al.
Publicado: (2019)